Telo Genomics Corp Stock Analysis

Telo OTC Stock Analysis Notes

The company recorded a loss per share of 0.03. Telo Genomics Corp last dividend was issued on the 22nd of November 2019. The entity had 1:5 split on the 22nd of November 2019. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada. TELO GENOMICS is traded on OTC Exchange in the United States.The quote for Telo Genomics Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Telo Genomics Corp contact , MSc at 416 673 8487 or learn more at https://www.telodx.com.

Telo Genomics Corp Investment Alerts

Telo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telo Genomics's market, we take the total number of its shares issued and multiply it by Telo Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 19th of December, Telo Genomics has the Semi Deviation of 9.22, coefficient of variation of 2320.14, and Risk Adjusted Performance of 0.0437. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telo Genomics Corp, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Telo Genomics Corp, which can be compared to its competition. Please validate Telo Genomics Corp treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Telo Genomics is priced more or less accurately, providing market reflects its prevalent price of 0.08 per share. As Telo Genomics Corp appears to be a penny stock we also recommend to double-check its total risk alpha numbers.

Telo Genomics Corp Price Movement Analysis

Telo Genomics Outstanding Bonds

Telo Genomics Predictive Daily Indicators

Telo Genomics Forecast Models

Telo Genomics' time-series forecasting models are one of many Telo Genomics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telo Genomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Telo Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telo shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Telo Genomics. By using and applying Telo OTC Stock analysis, traders can create a robust methodology for identifying Telo entry and exit points for their positions.

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.